Nalaganje...
Is There Still a Place for Tocilizumab in Coronavirus Disease 2019?
In this article, we sought to summarize the available evidence of tocilizumab as a treatment for coronavirus disease 2019. Recent tocilizumab randomized trials have not shown clear evidence of efficacy, especially on mortality, in contrast to observational studies. These clinical trials focus on a h...
Shranjeno v:
| izdano v: | Open Forum Infect Dis |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7890594/ https://ncbi.nlm.nih.gov/pubmed/33628858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab013 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|